These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341 [TBL] [Abstract][Full Text] [Related]
23. CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microL. Moore DM; Hogg RS; Yip B; Craib K; Wood E; Montaner JS HIV Med; 2006 Sep; 7(6):383-8. PubMed ID: 16903983 [TBL] [Abstract][Full Text] [Related]
24. Time-dependence of survival predictions based on markers of HIV disease. Swiss HIV Cohort Study. Perneger TV; Abrahamowicz M; Bartlett G; Yerly S J Investig Med; 2000 May; 48(3):207-12. PubMed ID: 10822902 [TBL] [Abstract][Full Text] [Related]
25. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment. Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932 [TBL] [Abstract][Full Text] [Related]
26. Dietary intake and counseling, weight maintenance, and the course of HIV infection. Chlebowski RT; Grosvenor M; Lillington L; Sayre J; Beall G J Am Diet Assoc; 1995 Apr; 95(4):428-32; quiz 433-5. PubMed ID: 7699184 [TBL] [Abstract][Full Text] [Related]
27. [The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons]. Günthard H; Opravil M; Ledergerber B; Olsson K; Vogt M; Fierz W; Lüthy R Dtsch Med Wochenschr; 1993 May; 118(20):737-45. PubMed ID: 8099005 [TBL] [Abstract][Full Text] [Related]
28. CD4+ cell counts and HIV-RNA levels do not predict outcomes of community-acquired pneumonia in hospitalized HIV-infected patients. Bordon J; Kapoor R; Martinez C; Portela D; Duvvuri P; Klochko A; Ayesu K; Peyrani P; Cillóniz C; Wiemken T; Parra A; Torres A; Rello J; Ramirez J Int J Infect Dis; 2011 Dec; 15(12):e822-7. PubMed ID: 21885316 [TBL] [Abstract][Full Text] [Related]
29. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. Ashton LJ; Carr A; Cunningham PH; Roggensack M; McLean K; Law M; Robertson M; Cooper DA; Kaldor JM AIDS Res Hum Retroviruses; 1998 Jan; 14(2):117-21. PubMed ID: 9462921 [TBL] [Abstract][Full Text] [Related]
30. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population. Roman M; Rodriguez JW; Pagán NO; Rios-Olivares E; Amill A; Hunter R P R Health Sci J; 2002 Sep; 21(3):195-201. PubMed ID: 12243109 [TBL] [Abstract][Full Text] [Related]
31. Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. McCombe JA; Vivithanaporn P; Gill MJ; Power C HIV Med; 2013 Feb; 14(2):99-107. PubMed ID: 22994556 [TBL] [Abstract][Full Text] [Related]
32. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy. Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L; AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104 [TBL] [Abstract][Full Text] [Related]
33. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062 [TBL] [Abstract][Full Text] [Related]
34. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977 [TBL] [Abstract][Full Text] [Related]
35. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
36. Effect of older age on survival in human immunodeficiency virus (HIV) disease. Martin JN; Colford JM; Ngo L; Tager IB Am J Epidemiol; 1995 Dec; 142(11):1221-30. PubMed ID: 7485069 [TBL] [Abstract][Full Text] [Related]
37. Immunohaematological findings in healthy and HIV-1 infected adults in Dar es Salaam, Tanzania. Urassa WK; Lyamuya EF; Mbena E; Kagoma C; Bredberg Raden U; Pallangyo KP; Magessa P; Mhalu FS; Biberfeld G East Afr Med J; 1996 Oct; 73(10):670-4. PubMed ID: 8997848 [TBL] [Abstract][Full Text] [Related]
38. Preoperative CD4 count or CD4/CD8 ratio as a useful indicator for postoperative sepsis in HIV-infected patients undergoing abdominal operations. Xia XJ; Liu BC; Su JS; Pei H; Chen H; Li L; Liu YF J Surg Res; 2012 May; 174(1):e25-30. PubMed ID: 22225978 [TBL] [Abstract][Full Text] [Related]
39. Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy. Chitra P; Bakthavatsalam B; Palvannan T Clin Chim Acta; 2011 May; 412(11-12):1151-4. PubMed ID: 21300045 [TBL] [Abstract][Full Text] [Related]
40. Transforming laboratory test results to improve clinical outcome predictions in HIV patients. Swiss HIV Cohort Study. Perneger TV; Yerly S; Perrin L J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(5):442-9. PubMed ID: 9562047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]